Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;98:617-625
Published online before print February 16, 2006, doi: 10.1161/01.RES.0000209968.66606.10
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
98/5/617    most recent
01.RES.0000209968.66606.10v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bodnar, R. J.
Right arrow Articles by Wells, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bodnar, R. J.
Right arrow Articles by Wells, A.
Related Collections
Right arrow Angiogenesis
Right arrow Cell signalling/signal transduction
Right arrow Other Vascular biology
(Circulation Research. 2006;98:617.)
© 2006 American Heart Association, Inc.


Molecular Medicine

IP-10 Blocks Vascular Endothelial Growth Factor-Induced Endothelial Cell Motility and Tube Formation via Inhibition of Calpain

Richard J. Bodnar, Cecelia C. Yates, Alan Wells

From the Department of Pathology, University of Pittsburgh, and the Pittsburgh Veterans Affairs Medical Center, Pa.

Correspondence to Richard J. Bodnar, Department of Pathology, University of Pittsburgh, S-709 Scaife Hall, Pittsburgh, PA 15261-0001. E-mail rjb8{at}pitt.edu

Angiogenesis plays a critical role in wound repair. Endothelial cells present CXC receptor 3 (CXCR3) for chemokines expressed late in wound regeneration. To understand the physiological role CXCR3 plays in regulating endothelial function, we analyzed the ability of a CXCR3 ligand, IP-10 (CXCL10), to influence endothelial cell tube formation. Treatment of endothelial cells with IP-10 in the presence of vascular endothelial growth factor (VEGF) inhibited tube formation on growth factor-reduced Matrigel and in a subcutaneous Matrigel plug. Furthermore, IP-10 significantly inhibited VEGF-induced endothelial motility, a response critical for angiogenesis. Previous work showed that CXCR3 ligandation initiates protein kinase A (PKA) phosphorylation-dependent inhibition of m-calpain, required for induced cell motility, in fibroblasts but not epithelial cells. Here we show that CXCR3 activation in endothelial cells induces an increase in cAMP and PKA activation. Treatment of endothelial cells with Rp-8-Br-cAMP, an inhibitor of PKA, or small interference RNA to PKA was able to reverse the inhibitory effects of IP-10 on VEGF-mediated tube formation and motility. Importantly, treatment of endothelial cells with VEGF induced the activation of m-calpain, but costimulation with IP-10 significantly decreased this activity. Using Rp-8-Br-cAMP, we show blocking PKA reversed the IP-10 inhibition of VEGF-induced m-calpain activity. These data indicate that the activation of CXCR3 inhibits endothelial tube formation through a PKA mediated inhibition of m-calpain. This provides a means by which late wound repair signals limit the angiogenesis driven early in the wound response process.


Key Words: CXCL10 • CXCR3 • angiogenesis • signal transduction • cAMP • receptor tyrosine kinase




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Xiong, Y. Huo, C. Chen, H. Zeng, X. Lu, C. Wei, C. Ruan, X. Zhang, Z. Hu, M. Shibuya, et al.
Vascular Endothelial Growth Factor (VEGF) Receptor-2 Tyrosine 1175 Signaling Controls VEGF-induced von Willebrand Factor Release from Endothelial Cells via Phospholipase C-{gamma}1- and Protein Kinase A-dependent Pathways
J. Biol. Chem., August 28, 2009; 284(35): 23217 - 23224.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
R. J. Bodnar, C. C. Yates, M. E. Rodgers, X. Du, and A. Wells
IP-10 induces dissociation of newly formed blood vessels
J. Cell Sci., June 15, 2009; 122(12): 2064 - 2077.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Funk, K. Kriechbaum, F. Prager, T. Benesch, M. Georgopoulos, G. J. Zlabinger, and U. Schmidt-Erfurth
Intraocular Concentrations of Growth Factors and Cytokines in Retinal Vein Occlusion and the Effect of Therapy with Bevacizumab
Invest. Ophthalmol. Vis. Sci., March 1, 2009; 50(3): 1025 - 1032.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. C. Yates, D. Whaley, A. Y-Chen, P. Kulesekaran, P. A. Hebda, and A. Wells
ELR-Negative CXC Chemokine CXCL11 (IP-9/I-TAC) Facilitates Dermal and Epidermal Maturation during Wound Repair
Am. J. Pathol., September 1, 2008; 173(3): 643 - 652.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. E. Goldfinger, E. Tzima, R. Stockton, W. B. Kiosses, K. Kinbara, E. Tkachenko, E. Gutierrez, A. Groisman, P. Nguyen, S. Chien, et al.
Localized {alpha}4 Integrin Phosphorylation Directs Shear Stress-Induced Endothelial Cell Alignment
Circ. Res., July 18, 2008; 103(2): 177 - 185.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. C. Yates, D. Whaley, P. Kulasekeran, W. W. Hancock, B. Lu, R. Bodnar, J. Newsome, P. A. Hebda, and A. Wells
Delayed and Deficient Dermal Maturation in Mice Lacking the CXCR3 ELR-Negative CXC Chemokine Receptor
Am. J. Pathol., August 1, 2007; 171(2): 484 - 495.
[Abstract] [Full Text] [PDF]